Related Experiment Video
Updated: Feb 11, 2026

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
Published on: August 11, 2008
The burden of multidrug-resistant tuberculosis in children
1Department of Biostatistics, Boston University School of Public Health, Boston.
Insights
Annually, 25,000-32,000 children contract multidrug-resistant tuberculosis (MDR-TB), but only a small fraction receive treatment. Prioritizing pediatric MDR-TB diagnosis and treatment is crucial for saving lives.
Area of Science:
- Global Health
- Infectious Diseases
- Pediatrics
Background:
- Childhood tuberculosis (TB) has been historically under-addressed.
- Recent efforts have increased focus on pediatric multidrug-resistant TB (MDR-TB).
- Estimating the global burden of pediatric MDR-TB remains a critical challenge.
Purpose of the Study:
- To review current global incidence estimates for pediatric MDR-TB.
- To generate mortality estimates for children with MDR-TB.
- To assess the potential of household contact investigations in identifying pediatric MDR-TB cases.
Main Methods:
- Review of global pediatric MDR-TB incidence data.
- Integration of WHO treatment data and pediatric TB case fatality ratios.
- Estimation of pediatric MDR-TB cases found through household contact investigations.
Main Results:
- An estimated 25,000–32,000 children develop MDR-TB annually, representing 3% of pediatric TB cases.
- Only 3–4% of these children receive necessary MDR-TB treatment.
- An estimated 21% of children with MDR-TB disease mortality; household contact investigations could identify 12 times more cases.
Conclusions:
- Pediatric MDR-TB diagnosis and treatment require urgent prioritization.
- Current treatment rates for pediatric MDR-TB are critically low.
- Household contact investigations represent a promising strategy for improved case detection.
Background:
Childhood tuberculosis (TB) has historically been neglected, although in recent years there has been increased focus on this problem. In particular, there have been two efforts to estimate the burden of pediatric multidrug-resistant TB (MDR-TB).
Methods:
We review current estimates of the global incidence of pediatric MDR-TB disease. We then combine pediatric MDR-TB treatment data from the World Health Organization and recently published case fatality ratio estimates for children with TB to produce mortality estimates for children with MDR-TB. Finally, we combine treatment data and estimates of household size and disease risk to estimate how many children could be treated for probable or confirmed MDR-TB by carrying out household contact investigations around adult MDR-TB patients.
Results:
Between 25 000 and 32 000 children develop MDR-TB disease annually, accounting for around 3% of all pediatric TB cases. Only 3-4% of these children are likely to receive MDR-TB treatment. We estimate that around 21% of children who develop MDR-TB disease will die. Carrying out household contact investigations around adult MDR-TB patients could find an estimated 12 times as many pediatric MDR-TB cases as are currently being identified.
Discussion:
The diagnosis and treatment of children with MDR-TB needs to be prioritized by TB programs.
More Related Videos
09:29In Vivo Investigation of Antimicrobial Blue Light Therapy for Multidrug-resistant Acinetobacter baumannii Burn Infections Using Bioluminescence Imaging
Published on: April 28, 2017
09:57Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
Published on: September 20, 2024
Related Concept Videos
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Resistivity
Resistance
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories: